Flutemetamol Terminated Phase 3 Trials for Alzheimer's Disease (AD) / Dementia / Mild Cognitive Impairment (MCI) Diagnostic

IndicationsStatusPurposePhase
TerminatedDiagnostic3
clinicaltrials.gov IdentifierTitleDrugs
NCT02353949Investigating the Clinical Consequences of Flutemetamol-PET-scanning